Tag: biomedical
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Antibody Clears Covid-19 Variants, Enters Trial
A synthetic antibody is shown in lab tests to neutralize variants of the SARS-CoV-2 virus, and will be added to an ongoing clinical trial of Covid-19 therapies.
-
Moderna Supplying 500M Vaccine Doses to Covax
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries.
-
Multiple Organs Impaired in Long Covid-19 Patients
A study of individuals with lingering symptoms from Covid-19 shows they experience impaired organ functions months after the initial infections.
-
Infographic – Covid-19 Vaccine Acceptance Gains Worldwide
Polling from across the world indicates that since the start of 2021, larger numbers of residents are vaccinated or plan to get vaccinated against the virus.
-
Trial Shows Malaria Vaccine Protects Young Children
Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections.
-
Trials Adding Covid-19 Hospital, Out-Patient Therapies
National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.